No definition available.
Bilateral cryptorchidism (undescended testicles)
Q17_BILATERAL_CRYPTORCHIDISM
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
88 |
4. Check minimum number of eventsNone |
88 |
5. Include endpointsNone |
88 |
6. Filter based on genotype QC (FinnGen only) |
69 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Bilateral cryptorchidism (undescended testicles)
based on the number of shared cases.
Similar with more cases:
- Undescended testicle
- Congenital malformations of genital organs
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 69 | - | 69 |
| Unadjusted period prevalence (%) | 0.03 | - | 0.03 |
| Median age at first event (years) | 4.32 | - | 4.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 78
- Matched controls
- 780
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
+∞
112.2
78
*
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
164.4
48.0
47
7
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
42.3
21.4
26
9
KFH10
NOMESCO Finland
Orchiopexy
46.9
17.8
21
6
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
8.2
15.7
26
45
ZXA10
NOMESCO Finland
Bilateral
6.4
14.6
35
88
R62.0
ICD-10 Finland
Delayed milestone
8.1
13.8
22
36
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
12.1
13.3
25
29
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
19.0
12.0
18
12
F83
ICD-10 Finland
Mixed specific developmental disorders
7.1
11.4
20
36
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.6
11.0
21
41
ZXE10
NOMESCO Finland
More than one and less than three hours
4.9
11.0
46
178
JAH01
NOMESCO Finland
Laparoscopy
23.9
10.2
14
7
H01AC01
ATC
somatropin; parenteral
6.7
10.2
19
36
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
5.3
10.1
26
67
Z3229
NOMESCO Finland
Other healthcare associate professional
5.3
10.1
26
67
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
11.7
9.4
17
18
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
9.2
45
189
ZXA05
NOMESCO Finland
Left side
5.0
9.2
25
67
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.3
9.0
34
118
ZXD20
NOMESCO Finland
Day surgery
5.6
9.0
20
45
121
Kela drug reimbursment
Severe hypofunction of sexual glands
56.6
8.9
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
4.2
8.8
49
224
F82
ICD-10 Finland
Specific developmental disorder of motor function
8.7
8.4
18
26
Z31.5
ICD-10 Finland
Genetic counselling
5.3
8.3
20
48
E29.1
ICD-10 Finland
Testicular hypofunction
37.7
8.3
10
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.1
8.1
31
108
ZXE20
NOMESCO Finland
More than three and less than five hours
4.6
8.0
24
69
602
Kela drug reimbursment
Children's severe malnutrition
8.4
7.8
17
25
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
7.3
26
85
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
7.3
31
115
FM2CE, ,
NOMESCO Finland
4.8
7.2
19
49
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.7
6.8
17
31
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.7
6.8
14
19
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
9.5
6.6
13
16
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
6.6
29
109
Q53.9
ICD-10 Finland
Undescended testicle, unspecified
75.8
6.5
7
*
7525A
ICD-9 Finland
Congenital anomalies of genital organs, Undescended testicle[RETENTIO TESTIS (CRYPTORCHISMUS)]
75.8
6.5
7
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
7.9
6.4
14
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.6
6.3
27
99
XA800
NOMESCO Finland
Neuropsychological investigation
4.0
6.3
22
70
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.8
6.3
16
40
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
108
6.89
16.54
5.7
2.3
11.10
12.81
nmol/l
0.51
41
100
29
69
6.10
12.59
3.7
2.5
7.17
3.85
u/l
0.92
18
41
25
56
6.10
11.47
3.8
2.7
11.73
5.89
iu/l
0.73
15
31
24
87
3.54
5.68
25.3
28.3
1.20
1.12
mg/l
0.33
24
87
18
62
3.47
4.53
3.3
11.3
92.22
92.32
%
0.01
18
62
28
134
2.70
3.97
3.1
4.2
—
—
—
0
0
20
91
2.61
3.06
2.6
6.1
1.36
2.05
mg/l
0.27
12
69
28
158
2.20
2.64
4.4
4.1
2.42
2.41
mmol/l
0.16
28
148
31
184
2.14
2.57
3.3
4.2
—
—
estimate
—
0
0
29
170
2.12
2.47
14.2
11.8
23.86
23.54
mmol/l
0.31
29
170
8
23
3.75
2.34
6.2
6.6
2.23
3.06
ug/l
—
8
23
7
18
4.16
2.31
3.6
6.6
58.73
69.08
%
—
7
18
8
25
3.44
2.16
1.9
2.6
—
—
—
0
0
12
50
2.65
2.15
3.7
7.8
183.00
166.32
%
0.44
12
50
37
248
1.94
2.12
8.6
4.3
0.00
0.00
estimate
—
7
39
7
20
3.74
2.11
1.9
4.9
1235.43
580.59
ug/l
—
7
20
7
21
3.55
2.01
1.7
2.7
—
—
—
0
0
36
244
1.88
1.96
8.7
4.3
0.00
0.00
estimate
—
7
46
36
245
1.87
1.93
8.7
4.3
0.00
0.00
estimate
—
7
42
8
30
2.85
1.78
5.3
21.3
23.04
23.42
mmol/l
—
8
30
55
436
1.89
1.75
5.3
3.3
15.04
14.77
pmol/l
0.40
55
410
5
13
4.03
1.74
4.6
3.5
21.60
23.31
umol/l
—
5
13
27
175
1.83
1.64
19.0
9.8
5.14
5.03
kpa
0.47
27
169
26
167
1.84
1.63
19.2
9.2
9.59
9.85
kpa
0.28
26
162
6
21
3.01
1.53
1.2
1.3
—
—
—
0
0
31
217
1.71
1.43
13.5
4.7
0.07
0.26
e6/l
0.86
26
163
6
23
2.74
1.39
1.3
2.6
0.89
0.17
nmol/l
—
6
18
48
384
1.65
1.30
5.6
3.4
1.17
1.17
mmol/l
0.01
48
363
8
39
2.17
1.19
1.9
2.5
—
—
—
0
0
8
39
2.17
1.19
2.5
2.0
—
—
—
0
0
7
30
2.46
1.15
1.9
2.3
—
—
—
0
0
7
32
2.30
1.11
3.0
1.5
358.14
412.53
mu/l
—
7
32
7
33
2.23
1.08
1.4
1.7
—
—
—
0
0
7
33
2.23
1.08
2.7
2.0
—
—
—
0
0
7
33
2.23
1.08
1.4
1.7
—
—
—
0
0
44
357
1.53
1.03
9.3
10.0
6.29
6.32
mmol/l
0.02
44
349
45
367
1.53
1.03
11.6
10.5
106.95
103.42
ml/min/173m2
0.35
34
284
0
28
0.00
1.00
0.0
1.1
—
—
—
0
0
0
28
0.00
1.00
0.0
1.1
—
—
—
0
0
18
119
1.67
0.99
2.7
1.7
102.45
99.81
pmol/l
—
8
50
27
199
1.55
0.96
23.3
15.7
25.57
24.96
mmol/l
0.46
27
199
31
238
1.50
0.91
13.6
5.3
—
—
—
0
0
6
29
2.16
0.91
2.7
3.2
—
—
—
0
0
6
30
2.08
0.89
9.5
4.9
—
—
—
0
0
6
31
2.01
0.86
9.7
4.7
17.67
8.32
%
—
6
31
0
24
0.00
0.80
0.0
1.0
—
4.74
—
0
5
0
25
0.00
0.80
0.0
7.6
—
—
—
0
0
20
144
1.52
0.78
9.6
4.5
1.14
0.44
e6/l
0.59
14
75
7
39
1.87
0.75
1.9
2.3
—
—
—
0
0
31
247
1.42
0.73
6.6
4.4
85.60
94.69
ug/l
0.16
31
237
15
107
1.50
0.61
12.7
3.9
0.00
0.00
estimate
—
5
37
20
152
1.42
0.60
9.9
3.8
0.00
0.00
estimate
—
5
42
8
54
1.54
0.59
3.8
2.1
—
—
—
0
0
14
99
1.50
0.59
12.5
6.2
4.21
11.31
umol/l
0.95
14
81
6
36
1.72
0.58
2.5
18.3
0.95
1.48
%
—
6
36
12
83
1.53
0.56
2.6
1.8
1.33
1.47
%
0.58
12
76
68
640
1.49
0.49
19.7
14.5
22.53
24.75
mg/l
0.25
55
447
50
451
1.30
0.47
14.7
16.1
3.62
3.62
e9/l
0.01
43
366
14
106
1.39
0.43
12.9
4.6
0.00
0.00
estimate
—
5
41
12
89
1.41
0.41
4.2
15.8
106.25
104.35
mmol/l
0.81
12
89
18
145
1.31
0.38
10.4
4.4
0.45
0.36
e6/l
0.08
13
76
12
91
1.38
0.36
2.6
2.3
—
—
—
0
0
5
39
1.30
0.23
1.6
1.7
—
—
—
0
0
10
80
1.29
0.22
1.9
2.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
0.34
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
3.8
—
19.18
—
0
6
0
12
0.00
0.21
0.0
1.2
—
0.59
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
9
79
1.16
0.16
1.9
2.3
—
—
—
0
0
26
280
0.89
0.13
2.4
1.8
—
—
—
0
0
11
125
0.86
0.11
3.5
2.6
—
—
—
0
0
9
84
1.08
0.07
1.0
1.1
—
—
—
0
0
11
118
0.92
0.03
3.2
2.5
—
—
—
0
0
60
605
0.96
0.00
4.1
3.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.00
—
0
6
0
6
0.00
-0.00
0.0
3.2
—
22.33
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.00
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
115.20
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
13.20
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.00
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.6
—
59.00
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
12.86
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
123.43
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
108.50
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.7
—
1021.29
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
125.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
29.37
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
-0.00
2.4
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_BILATERAL_CRYPTORCHIDISM – Bilateral cryptorchidism (undescended testicles)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).